Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
about
Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine releaseDeficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin DeficiencyFreezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary DiseasesGenome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study.Chronic obstructive pulmonary disease: towards pharmacogenetics.Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsinDetermination of alpha-1 antitrypsin level in patients with severe asthma.Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations.One hundred years of chronic obstructive pulmonary disease.Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipientsThe genetics of chronic obstructive pulmonary disease.Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometryRapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screeningA Library of Rare α1-Antitrypsin (AAT) Variant Phenotypes to Aid in the Diagnosis of AAT Deficiency.Smoking and the incidence of asthma during adolescence: results of a large cohort study in GermanyPreoperative assessment of the patient with liver disease.The role of iron in pulmonary pathology.The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiencyImproving diagnosis and management of alpha-1 antitrypsin deficiency in primary care: translating knowledge into action.Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).Molecular diagnostics of α1-antitrypsin deficiency.Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.Benefits Among Patients with Alpha-1 Antitrypsin Deficiency Enrolled in a Disease Management and Prevention ProgramGenotypes and serum concentrations of human alpha-1-antitrypsin "P" protein variants in a clinical population.Unusually difficult clinical presentation of an infant suffering from congenital Cytomegalovirus (CMV) infection combined with alpha 1-antitrypsin (A1AT) deficiencyAlpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency.Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases.The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.A patient with the rare alpha-1-antitrypsin variant (Z)bristol in compound heterozygosity with the Z mutation.Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.α1-Antitrypsin deficiency.Deficiência de alfa-1 antitripsina: diagnóstico e tratamento
P2860
Q24804783-17713D1D-8598-4653-8A45-8BA867FB4DE0Q27348851-EA14BC08-9ECC-4EAD-B207-31271F8632E2Q28646482-04C5D25A-6F79-4736-9F0A-8E674A83AB4CQ30408059-698FD65E-DAC4-42F3-A492-66560740F57FQ33600138-F5F7339C-D8C8-439A-8329-0E7FD90A44D9Q33649874-11D92CFE-26B5-4BB0-B2CF-5D64576FF4FDQ34080880-A8E13C35-9B48-4868-BBAC-4D8094FF0D96Q34126916-4ADADB64-14D3-46BB-AE1D-25772762995CQ34149948-10F27771-50FF-4E4D-A9B3-44ADB50EF1BBQ34295276-B8CD3D06-E020-4B51-93DA-9E4A3E72A156Q34413510-9932B6A9-1CF0-4CEF-9C8F-ECC68501D483Q34497165-40B3A118-2BF2-4FAD-80C2-A4F7C9CE1C97Q35113365-DDC3A3C0-025B-4586-B48C-9BD90E4395E5Q35746195-B21FDBA7-A9AB-491B-8259-2031580B1075Q35789532-BCAF2A11-CDD1-4EA7-A4F8-4607E7482BABQ36108481-690C628A-20FC-452C-B6C0-EF53F0EED997Q36184083-9B9B6ABB-EAAE-4572-9561-E41B8508CA08Q36243486-62BA8F7A-8FF1-4D82-8E04-C092483879D2Q36336719-1F992EB8-5088-496E-A186-DD8112CCB115Q36782392-1F04C695-53BD-4FF2-88EB-9885BA5ABB07Q37756938-F4C7665E-76A9-4828-9424-AC1E898251C2Q38079492-62535B37-9131-423C-885C-645BF0CB9381Q38089248-78A5427B-1052-41B2-A44A-AABFD784B561Q38114852-F140E4FD-42B6-45EB-8D62-5AB58D4A4EABQ38604612-44C0BF34-9B1A-4EBE-B9F4-2F05522E6FF6Q41608096-1F2A85BB-55FD-4BDF-B453-21BCE04862B4Q41686334-4C41A579-3B76-468A-B62F-F27CE3999607Q42592799-AF6CA58A-D017-46D0-99EB-29E7C35DE909Q46227261-B4E1242D-6C38-4D08-BBBD-980DC600076EQ46889766-7496E093-4DFD-4AF0-A197-C53B0115D677Q47149343-74DB0BA4-DA95-4032-AE2E-D928FC69146FQ47999752-2795405E-BAED-4D67-905D-BD45D4802E5FQ51465416-2E4A4D1D-0586-4827-845F-A15CAD1E93DCQ51481224-DA9F9D1A-0B43-4BE3-B6C3-53D77699E91CQ57778139-CEAD72CE-1198-4ECF-AD0D-D8239B0AFE5E
P2860
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@ast
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@en
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@nl
type
label
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@ast
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@en
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@nl
prefLabel
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@ast
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@en
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@nl
P2860
P356
P1433
P1476
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history
@en
P2093
R A Stockley
P2860
P356
10.1136/THX.2003.006510
P407
P577
2004-05-01T00:00:00Z